These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 31288997)

  • 1. Development of suspension adapted Vero cell culture process technology for production of viral vaccines.
    Shen CF; Guilbault C; Li X; Elahi SM; Ansorge S; Kamen A; Gilbert R
    Vaccine; 2019 Nov; 37(47):6996-7002. PubMed ID: 31288997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adaptation of Vero cells to suspension growth for rabies virus production in different serum free media.
    Rourou S; Ben Zakkour M; Kallel H
    Vaccine; 2019 Nov; 37(47):6987-6995. PubMed ID: 31201054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suspension-Vero cell cultures as a platform for viral vaccine production.
    Paillet C; Forno G; Kratje R; Etcheverrigaray M
    Vaccine; 2009 Oct; 27(46):6464-7. PubMed ID: 19559123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioreactor production of rVSV-based vectors in Vero cell suspension cultures.
    Kiesslich S; Kim GN; Shen CF; Kang CY; Kamen AA
    Biotechnol Bioeng; 2021 Jul; 118(7):2649-2659. PubMed ID: 33837958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficient influenza A virus production in high cell density using the novel porcine suspension cell line PBG.PK2.1.
    Gränicher G; Coronel J; Pralow A; Marichal-Gallardo P; Wolff M; Rapp E; Karlas A; Sandig V; Genzel Y; Reichl U
    Vaccine; 2019 Nov; 37(47):7019-7028. PubMed ID: 31005427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum-free microcarrier based production of replication deficient influenza vaccine candidate virus lacking NS1 using Vero cells.
    Chen A; Poh SL; Dietzsch C; Roethl E; Yan ML; Ng SK
    BMC Biotechnol; 2011 Aug; 11():81. PubMed ID: 21835017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved poliovirus D-antigen yields by application of different Vero cell cultivation methods.
    Thomassen YE; Rubingh O; Wijffels RH; van der Pol LA; Bakker WA
    Vaccine; 2014 May; 32(24):2782-8. PubMed ID: 24583004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retroviral vector production using suspension-adapted 293GPG cells in a 3L acoustic filter-based perfusion bioreactor.
    Ghani K; Garnier A; Coelho H; Transfiguracion J; Trudel P; Kamen A
    Biotechnol Bioeng; 2006 Nov; 95(4):653-60. PubMed ID: 16947907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development, optimization, and scale-up of suspension Vero cell culture process for high titer production of oncolytic herpes simplex virus-1.
    Shen CF; Burney E; Gilbert R; Elahi SM; Parato K; Loignon M
    Biotechnol J; 2024 Jan; 19(1):e2300244. PubMed ID: 37767876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A microcarrier cell culture process for propagating rabies virus in Vero cells grown in a stirred bioreactor under fully animal component free conditions.
    Rourou S; van der Ark A; van der Velden T; Kallel H
    Vaccine; 2007 May; 25(19):3879-89. PubMed ID: 17307281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Purification of rabies virus produced in Vero cells grown in serum free medium.
    Trabelsi K; Ben Zakour M; Kallel H
    Vaccine; 2019 Nov; 37(47):7052-7060. PubMed ID: 31300287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimization of production of vesicular stomatitis virus (VSV) in suspension serum-free culture medium at high cell density.
    Elahi SM; Shen CF; Gilbert R
    J Biotechnol; 2019 Jan; 289():144-149. PubMed ID: 30508556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An animal component free medium that promotes the growth of various animal cell lines for the production of viral vaccines.
    Rourou S; Ben Ayed Y; Trabelsi K; Majoul S; Kallel H
    Vaccine; 2014 May; 32(24):2767-9. PubMed ID: 24583007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pseudorabies virus production using a serum-free medium in fixed-bed bioreactors with low cell inoculum density.
    Nie J; Sun Y; Peng F; Han F; Yang Y; Liu X; Liu C; Li Y; Bai Z
    Biotechnol Lett; 2020 Dec; 42(12):2551-2560. PubMed ID: 32816175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum-free production of rVSV-ZEBOV in Vero cells: Microcarrier bioreactor versus scale-X™ hydro fixed-bed.
    Kiesslich S; Vila-Chã Losa JP; Gélinas JF; Kamen AA
    J Biotechnol; 2020 Feb; 310():32-39. PubMed ID: 32006630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancing enterovirus A71 vaccine production yield by microcarrier profusion bioreactor culture.
    Liu CC; Wu SC; Wu SR; Lin HY; Guo MS; Yung-Chih Hu A; Chow YH; Chiang JR; Shieh DB; Chong P
    Vaccine; 2018 May; 36(22):3134-3139. PubMed ID: 28274636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Propagation of Brazilian Zika virus strains in static and suspension cultures using Vero and BHK cells.
    Nikolay A; Castilho LR; Reichl U; Genzel Y
    Vaccine; 2018 May; 36(22):3140-3145. PubMed ID: 28343780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum-Free Suspension Culture of MDCK Cells for Production of Influenza H1N1 Vaccines.
    Huang D; Peng WJ; Ye Q; Liu XP; Zhao L; Fan L; Xia-Hou K; Jia HJ; Luo J; Zhou LT; Li BB; Wang SL; Xu WT; Chen Z; Tan WS
    PLoS One; 2015; 10(11):e0141686. PubMed ID: 26540170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies on high-density cultivation of Vero cells with biosilon solid microcarrier.
    Wang D; Xiao C; Chen Z; Huang Z
    Chin J Biotechnol; 1996; 12(2):119-29. PubMed ID: 8988358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Adherent and single-cell suspension culture of Madin-Darby canine kidney cells in serum-free medium].
    Huang D; Zhao L; Tan W
    Sheng Wu Gong Cheng Xue Bao; 2011 Apr; 27(4):645-52. PubMed ID: 21848001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.